Cash Flow from Operating Activities: A company's cash flows from operations.
Taysha Gene Therapies, Inc. (TSHA) had Cash Flow from Operating Activities of $-93.09M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$9.77M |
|
$-109.00M |
|
-- |
|
$9.77M |
|
$120.27M |
|
$-110.50M |
|
$1.50M |
|
$-109.00M |
|
$-109.00M |
|
$-109.00M |
|
$-109.00M |
|
$-109.00M |
|
$-109.00M |
|
$-110.50M |
|
$-109.35M |
|
319.71M |
|
319.71M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$324.65M |
|
$6.74M |
|
$18.67M |
|
$343.32M |
|
$26.55M |
|
$50.11M |
|
$69.83M |
|
$96.38M |
|
$246.94M |
|
$246.94M |
|
$246.94M |
|
285.05M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-93.09M |
$-0.60M |
|
$274.59M |
|
$141.64M |
|
$322.53M |
|
$180.90M |
|
$13.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.23 |
|
-- |
|
-- |
|
0.17 |
|
0.20 |
|
100.00% |
|
-1130.65% |
|
-1130.65% |
|
-1118.93% |
|
-1115.27% |
|
-1115.27% |
|
$-93.83M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-44.14% |
|
-44.14% |
|
-31.75% |
|
-36.69% |
|
$0.87 |
|
$-0.29 |
|
$-0.29 |
|